126 related articles for article (PubMed ID: 22110198)
21. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
23. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
25. Antisense inhibition of amphiregulin expression reduces EGFR phosphorylation in transformed human breast epithelial cells.
Ma L; Huet E; Serova M; Berthois Y; Calvo F; Mourah S; Menashi S
Anticancer Res; 2010 Jun; 30(6):2101-6. PubMed ID: 20651357
[TBL] [Abstract][Full Text] [Related]
26. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
[TBL] [Abstract][Full Text] [Related]
27. Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells.
Kim S; Kil WH; Lee J; Oh SJ; Han J; Jeon M; Jung T; Lee SK; Bae SY; Lee HC; Lee JH; Yi HW; Kim SW; Nam SJ; Lee JE
Oncol Rep; 2014 Dec; 32(6):2666-72. PubMed ID: 25269647
[TBL] [Abstract][Full Text] [Related]
28. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
29. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
30. Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways.
El Hiani Y; Lehen'kyi V; Ouadid-Ahidouch H; Ahidouch A
Arch Biochem Biophys; 2009 Jun; 486(1):58-63. PubMed ID: 19332022
[TBL] [Abstract][Full Text] [Related]
31. On the nanotoxicity of PAMAM dendrimers: Superfect® stimulates the EGFR-ERK1/2 signal transduction pathway via an oxidative stress-dependent mechanism in HEK 293 cells.
Akhtar S; Chandrasekhar B; Attur S; Yousif MH; Benter IF
Int J Pharm; 2013 May; 448(1):239-46. PubMed ID: 23538097
[TBL] [Abstract][Full Text] [Related]
32. Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells.
Kim S; Jeon M; Lee J; Han J; Oh SJ; Jung T; Nam SJ; Kil WH; Lee JE
Oncol Rep; 2014 Nov; 32(5):2230-6. PubMed ID: 25175149
[TBL] [Abstract][Full Text] [Related]
33. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.
Kim S; Han J; Lee SK; Choi MY; Kim J; Lee J; Jung SP; Kim JS; Kim JH; Choe JH; Lee JE; Nam SJ
J Surg Res; 2012 Jul; 176(1):e21-9. PubMed ID: 22381172
[TBL] [Abstract][Full Text] [Related]
34. CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.
Xu H; Wu K; Tian Y; Liu Q; Han N; Yuan X; Zhang L; Wu GS; Wu K
Int J Oncol; 2016 Oct; 49(4):1343-50. PubMed ID: 27499099
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion.
Ma L; Lan F; Zheng Z; Xie F; Wang L; Liu W; Han J; Zheng F; Xie Y; Huang Q
Mol Cancer; 2012 Oct; 11():79. PubMed ID: 23083134
[TBL] [Abstract][Full Text] [Related]
36. Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Oh SJ; Jung SP; Han J; Kim S; Kim JS; Nam SJ; Lee JE; Kim JH
Oncol Rep; 2013 Apr; 29(4):1343-8. PubMed ID: 23353996
[TBL] [Abstract][Full Text] [Related]
37. Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms.
Anestopoulos I; Kavo A; Tentes I; Kortsaris A; Panayiotidis M; Lazou A; Pappa A
J Nutr Biochem; 2013 Mar; 24(3):586-94. PubMed ID: 22818713
[TBL] [Abstract][Full Text] [Related]
38. EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Cho S; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH
Cell Signal; 2009 Jun; 21(6):892-8. PubMed ID: 19385051
[TBL] [Abstract][Full Text] [Related]
39. Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.
Kim S; Han J; Lee SK; Koo M; Cho DH; Bae SY; Choi MY; Kim JS; Kim JH; Choe JH; Yang JH; Nam SJ; Lee JE
Cancer Lett; 2012 Jan; 314(2):147-54. PubMed ID: 22033246
[TBL] [Abstract][Full Text] [Related]
40. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
Tyagi A; Sharma Y; Agarwal C; Agarwal R
Pharm Res; 2008 Sep; 25(9):2143-50. PubMed ID: 18253818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
